Ann has over 35 years experience in Drug Discovery and Development in the Pharmaceutical industry.
Ann Lewis has over 35 years experience in Drug Discovery and Development in the pharmaceutical industry and has co-authored 16 scientific publications.
Beginning her career at Weddel Pharmaceuticals and progressing to more senior roles at SK&F and then SmithKline Beecham, Ann became a section head within Preclinical Discovery where she held responsibility for drug metabolism and pharmacokinetic (DMPK) data in support of Target-to-Lead and Lead-to-Candidate packages for projects in the neuroscience, pain, GI and cardiovascular disease areas.
Following the SB/Glaxo merger in 2000, Ann became Head of DMPK Operations and Outsourcing within GSK’s Neurology Centre of Excellence for Drug Discovery, successfully building a flexible and cost-effective outsourced capability.
In 2011 she joined the biotech Cellzome as a DMPK consultant where she integrated internal Project Teams and external CROs to drive compound progression towards Candidate Selection.
Since 2013 Ann has successfully delivered several client-based drug discovery assignments through Xenovium and continues to coordinate all business administration activities.
Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL